Compounds > phenytoin

phenytoin and methazolamide

phenytoin has been researched along with methazolamide in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19904 (57.14)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (28.57)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL1
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1
Gray, WD; Rauh, CE3
GRAY, WD; LIPCHUCK, LM; OSTERBERG, AC; RAUH, CE1

Reviews

1 review(s) available for phenytoin and methazolamide

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

6 other study(ies) available for phenytoin and methazolamide

ArticleYear
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
    PloS one, 2016, Volume: 11, Issue:10

    Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat

2016
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023
The anticonvulsant action of the carbonic anhydrase inhibitor methazolamide: possible involvement of a noradrenergic mechanism.
    European journal of pharmacology, 1974, Volume: 28, Issue:1

    Topics: Animals; Anticonvulsants; Benserazide; Body Temperature; Carbonic Anhydrase Inhibitors; Dihydroxyphenylalanine; Dopamine beta-Hydroxylase; Dose-Response Relationship, Drug; Electroshock; Ethanolamines; Isoproterenol; Levobunolol; Male; Methazolamide; Mice; Motor Activity; Norepinephrine; Phenoxybenzamine; Phentolamine; Phenytoin; Practolol; Propranolol; Rats; Reserpine; Serotonin; Thiazoles; Thiourea; Tolazoline

1974
The relation between monoamines in brain and the anticonvulsant action of inhibition of carbonic anhydrase.
    The Journal of pharmacology and experimental therapeutics, 1971, Volume: 177, Issue:1

    Topics: Amines; Animals; Anticonvulsants; Brain Chemistry; Carbonic Anhydrase Inhibitors; Dopamine; Drug Synergism; Fenclonine; Male; Methazolamide; Methyltyrosines; Norepinephrine; Phenytoin; Rats; Reserpine; Serotonin

1971
The anticonvulsant action of inhibitors of carbonic anhydrase: relation to endogenous amines in brain.
    The Journal of pharmacology and experimental therapeutics, 1967, Volume: 155, Issue:1

    Topics: Animals; Brain Chemistry; Carbonic Anhydrase Inhibitors; Dopamine; Iproniazid; Male; Methazolamide; Mice; Norepinephrine; Phenobarbital; Phenytoin; Reserpine; Serotonin

1967
The anticonvulsant actions of methazolamide (a carbonic anhydrase inhibitor) and diphenylhydantoin.
    The Journal of pharmacology and experimental therapeutics, 1958, Volume: 124, Issue:2

    Topics: Acetazolamide; Anticonvulsants; Carbonic Anhydrase Inhibitors; Hydantoins; Methazolamide; Phenytoin

1958